179 related articles for article (PubMed ID: 23955683)
21. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
22. Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy.
Mohsenzadegan M; Tajik N; Madjd Z; Shekarabi M; Farajollahi MM
Med J Islam Repub Iran; 2015; 29():159. PubMed ID: 26000254
[TBL] [Abstract][Full Text] [Related]
23. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
[TBL] [Abstract][Full Text] [Related]
24. Expression of store-operated channel components in prostate cancer: the prognostic paradox.
Perrouin Verbe MA; Bruyere F; Rozet F; Vandier C; Fromont G
Hum Pathol; 2016 Mar; 49():77-82. PubMed ID: 26826413
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry.
Yang B; Sun H; Lin W; Hou W; Li H; Zhang L; Li F; Gu Y; Song Y; Li Q; Zhang F
Urol Oncol; 2013 Jul; 31(5):628-34. PubMed ID: 21704537
[TBL] [Abstract][Full Text] [Related]
26. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M
Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157
[TBL] [Abstract][Full Text] [Related]
27. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic significance of overexpression of Golgi membrane protein 1 in prostate cancer.
Li W; Wang X; Li B; Lu J; Chen G
Urology; 2012 Oct; 80(4):952.e1-7. PubMed ID: 22840862
[TBL] [Abstract][Full Text] [Related]
29. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
30. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.
Marx A; Koopmann L; Höflmayer D; Büscheck F; Hube-Magg C; Steurer S; Eichenauer T; Clauditz TS; Wilczak W; Simon R; Sauter G; Izbicki JR; Huland H; Heinzer H; Graefen M; Haese A; Schlomm T; Bernreuther C; Lebok P; Bonk S
Cancer Biol Med; 2021 Feb; 18(1):245-255. PubMed ID: 33628598
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer.
Hua X; Yu L; Pan W; Huang X; Liao Z; Xian Q; Fang L; Shen H
Diagn Pathol; 2012 Sep; 7():127. PubMed ID: 23006319
[TBL] [Abstract][Full Text] [Related]
32. Reduced cytoplasmic expression of MAGE-A2 predicts tumor aggressiveness and survival: an immunohistochemical analysis.
Khalvandi A; Abolhasani M; Madjd Z; Sharifi L; Bakhshi P; Mohsenzadegan M
World J Urol; 2021 Jun; 39(6):1831-1843. PubMed ID: 32772147
[TBL] [Abstract][Full Text] [Related]
33. Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy.
Wu JP; Huang WB; Zhou H; Xu LW; Zhao JH; Zhu JG; Su JH; Sun HB
Asian J Androl; 2014; 16(5):710-4. PubMed ID: 24875819
[TBL] [Abstract][Full Text] [Related]
34. Role of androgen receptor in prostatic neoplasia versus hyperplasia.
Husain I; Shukla S; Soni P; Husain N
J Cancer Res Ther; 2016; 12(1):112-6. PubMed ID: 27072221
[TBL] [Abstract][Full Text] [Related]
35. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
[TBL] [Abstract][Full Text] [Related]
37. Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade.
Perrone G; Vincenzi B; Zagami M; Santini D; Panteri R; Flammia G; Verzì A; Lepanto D; Morini S; Russo A; Bazan V; Tomasino RM; Morello V; Tonini G; Rabitti C
Mod Pathol; 2007 Mar; 20(3):344-51. PubMed ID: 17277764
[TBL] [Abstract][Full Text] [Related]
38. SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.
Bauman TM; Becka AJ; Sehgal PD; Huang W; Ricke WA
Hum Pathol; 2015 Nov; 46(11):1744-51. PubMed ID: 26344417
[TBL] [Abstract][Full Text] [Related]
39. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
Cao W; Li F; Yao J; Yu J
BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
[TBL] [Abstract][Full Text] [Related]
40. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Parsons JK; Gage WR; Nelson WG; De Marzo AM
Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
